SCHEMBL8249490

SCHEMBL8249490

O=C(O)CCc1ccc(NS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.76
ALDH1A1 P00352 5/20 0.76
HDAC8 Q9BY41 4/20 0.76
HDAC4 P56524 1/20 0.76
POLB P06746 1/20 0.72
TDP1 Q9NUW8 1/20 0.72
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
HTR6 P50406 1/20 0.68
LIMK2 P53671 1/20 0.64
MAPT P10636 1/20 0.62
PKM P14618 1/20 0.59
IL1RN P18510 1/20 0.58
KEAP1 Q14145 1/20 0.58
ERAP1 Q9NZ08 1/20 0.58
IDO1 P14902 1/20 0.57
FFAR1 O14842 1/20 0.56
FFAR4 Q5NUL3 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2692935 0.91 HDAC1 (0.78) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL2691131 0.90 HDAC1 (0.78) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL14187853 0.88 HDAC1 (0.72) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL1405096 0.88 HDAC1 (0.72) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL8076558 0.87 ALDH1A1 (1.00) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL2692273 0.87 HDAC1 (1.00) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL8867856 0.84 HTR6 (0.71) HDAC1ALDH1A1HDAC8HDAC4MEN1
SCHEMBL5205017 0.84 HDAC1 (0.75) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL3563796 0.83 HDAC1 (0.66) HDAC1ALDH1A1HDAC8HDAC4POLB
SCHEMBL8867847 0.82 HTR6 (0.73) HDAC1ALDH1A1HDAC8HDAC4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796330-B2 Inhibitors of histone deacetylase and prodrugs thereof METHYLGENE INC. (CA) 2014-08-05 US disclosed
US-8796330-B2 Inhibitors of histone deacetylase and prodrugs thereof METHYLGENE INC. (CA) 2014-08-05 US disclosed
US-20140024608-A1 INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF METHYLGENE INC. (CA) 2014-01-23 US disclosed
US-20140024608-A1 INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF METHYLGENE INC. (CA) 2014-01-23 US disclosed
US-20080146623-A1 INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF METHYLGENE INC. (CA) 2008-06-19 US disclosed
US-RE39850-E1 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents METHYLGENE, INC. (CA) 2007-09-18 US disclosed
US-RE39850-E1 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents METHYLGENE, INC. (CA) 2007-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146623-A1 INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF HDAC1, HDAC3, HDAC11 HDAC1 1/4885ALDH1A1 521/4885HDAC8 9/4885
US-20140024608-A1 INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF HDAC1, HDAC3, HDAC11 HDAC1 1/4885ALDH1A1 521/4885HDAC8 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.